Keywords

Amyloidosis; Aortic Valve Stenosis; Cardiac Imaging Techniques; Endomyocardial Fibrosis; Heart Failure; Magnetic Resonance Imaging; Mitral Valve; Multidetector Computed Tomography; Tricuspid Valve

Research interests

My main research focus is to improve outcome prediction in valvular heart disease using multimodality imaging. Our lab has a strong focus on non-invasive myocardial tissue characterization by cardiovascular magnetic resonance but strives to combine state of the art imaging workup from a broad range of diagnostic modalities (e.g. nuclear imaging techniques, echocardiography, multidetector computed tomography)

Techniques, methods & infrastructure

State of the art echocardiography, CMR, and nuclear imaging

Selected publications

1. Nitsche, C. et al. (2021) ‘Prevalence and Outcomes of Concomitant Aortic Stenosis and Cardiac Amyloidosis’, Journal of the American College of Cardiology, 77(2), pp. 128–139. Available at: http://dx.doi.org/10.1016/j.jacc.2020.11.006.
2. Nitsche, C. et al. (2020) ‘Light‐chain and transthyretin cardiac amyloidosis in severe aortic stenosis: prevalence, screening possibilities, and outcome’, European Journal of Heart Failure, 22(10), pp. 1852–1862. Available at: http://dx.doi.org/10.1002/ejhf.1756.
3. Nitsche, C. et al. (2021) ‘Volume Status Impacts CMR–Extracellular Volume Measurements and Outcome in AS Undergoing TAVR’, JACC: Cardiovascular Imaging, 14(2), pp. 516–518. Available at: http://dx.doi.org/10.1016/j.jcmg.2020.08.010.
4. Nitsche, C. et al. (2020) ‘Determinants of Bioprosthetic Aortic Valve Degeneration’, JACC: Cardiovascular Imaging, 13(2), pp. 345–353. Available at: http://dx.doi.org/10.1016/j.jcmg.2019.01.027.
5. Nitsche, C. et al. (2021) ‘Fluid overload in patients undergoing TAVR: what we can learn from the nephrologists’, ESC Heart Failure, 8(2), pp. 1408–1416. Available at: http://dx.doi.org/10.1002/ehf2.13226.